Phillip Thienger

University of Bern

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

University of Bern

Research Subjects

Prostate Cancer

Research Interests

Phillip Thienger has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

Mark A. Rubin
Department for BioMedical Research, University of Bern, Bern, Switzerland
18 shared publications
Alden King-Yung Leung
School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China
16 shared publications
Alina Naveed
University of Bern 1 Department for Biomedical Research Bern, Switzerland
16 shared publications
Andrej Benjak
Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland
16 shared publications
Bence Daniel
Department of Proteomic and Genomic Technologies, Genentech, South San Francisco, USA
16 shared publications
Charlotte Kiu Yan Ng
IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy
16 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S13 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S13 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
Open Access
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
A947-treatment consistently modulates lineage-defining CRPCWNT signature and master TFs
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S5 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
A947-treatment consistently modulates lineage-defining CRPCWNT signature and master TFs
Open Access
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
A947-treatment leads to decreased chromatin accessibility in CRPC-WNT
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S7 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
A947-treatment leads to decreased chromatin accessibility in CRPC-WNT
Open Access
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
Drug screen with SMARCA2/4 degrader
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S1 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
Drug screen with SMARCA2/4 degrader
Open Access
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S11 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
TCF7L2 chromatin binding is reduced upon treatment with A947 in CRPC-WNT
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S11 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
TCF7L2 chromatin binding is reduced upon treatment with A947 in CRPC-WNT
Open Access
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
CRPC-WNT organoids are SMARCA4 but not SMARCA2 dependent
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S3 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
CRPC-WNT organoids are SMARCA4 but not SMARCA2 dependent
Open Access
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
CRPC-WNT organoids become deregulated in multiple proliferative pathways upon SMARCA2/4 degradation
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S6 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
CRPC-WNT organoids become deregulated in multiple proliferative pathways upon SMARCA2/4 degradation
Open Access
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S12 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
TCF7L2 regulates pro-proliferative pathways in CRPC-WNT
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S12 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
TCF7L2 regulates pro-proliferative pathways in CRPC-WNT
Open Access
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
The TCF7L2 promoter interacts with an intragenic enhancer that is kept accessible by the SWI/SNF complex
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S9 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
The TCF7L2 promoter interacts with an intragenic enhancer that is kept accessible by the SWI/SNF complex
Open Access
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
CRPC-WNT is dependent on TCF7L2
Website
Google Scholar
- 2 April 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S8 from A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules
by Phillip Thienger, Irene Paassen, Xiaosai Yao, Philip D. Rubin, Marika Lehner, Nicholas Lillis, Andrej Benjak, Sagar R. Shah, Alden King-Yung Leung, Simone de Brot, et al.
CRPC-WNT is dependent on TCF7L2

Show all